Immunic Inc.

IMUX | NASDAQ

Price Alert Chart Builder DCF Calculator

$11.03

+$0.20 (+1.85%)

Sep 22, 2026, 9:44 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $147.52M

Enterprise Value $-7.01M

Beta 1.41

Average Volume 221.32K

Shares Outstanding (Diluted) 42.51M

Shares Change YoY 221.65%

Institutional Ownership 21.22%

Exchange NASDAQ

ISIN US4525EP2001

Price Performance

Price Change 1M -34.0%

Price Change 3M -28.1%

Price Change 6M -17.9%

Price Change YTD 85.8%

Price Change 1Y 19.1%

Price Change 3Y -20.4%

Price Change 5Y -88.3%

1M CAGR (ann.) -24.3%

1Y CAGR (ann.) 28.9%

5Y CAGR (ann.) -35.5%

All-Time CAGR -38.7%

Valuation

PE Ratio -2.26

Forward PE N/A

PEG Ratio -0.03

Forward PEG 0.07

PS Ratio N/A

Forward PS 11.80

PB Ratio 1.16

P/FCF Ratio -1.68

P/Adj. FCF Ratio -1.42

P/OCF Ratio -5.26

EV/Sales N/A

EV/EBIT 0.06

EV/EBITDA 0.06

EV/FCF 0.08

Earnings Yield -44.3%

FCF Yield -59.7%

Adj. FCF Yield -70.7%

Financial Health

Net Cash $155.1M

Total Debt $567K

Cash & Short-Term Investments $155.1M

Total Assets $159.17M

Current Ratio 5.05

Quick Ratio 5.05

Debt / Equity Ratio 0.00

Debt / EBITDA -0.01

Debt / FCF -0.01

OCF / Debt -154.71

Interest Coverage 0.00

Altman Z-Score -4.50

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -18.4%

Returns

Return on Assets -70.1%

Return on Equity -157.9%

Return on Invested Capital -92.0%

Return on Capital Employed -92.2%

Return on Tangible Assets -70.1%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y -54.5%

EPS CAGR 3Y 52.1%

EPS CAGR 5Y 40.1%

EPS CAGR 10Y 29.4%

FCF CAGR 3Y -9.1%

FCF CAGR 5Y -5.3%

FCF CAGR 10Y -10.5%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 12

EPS Growth Next 3Y 29.2%

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.94

EPS Growth Est (next Q) -27.6%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $22.13

Price Target Upside 104.3%

Cash Flow

Operating Cash Flow $-87.72M

Free Cash Flow $-88.05M

Adj. Free Cash Flow $-104.22M

FCF Per Share -$2.07

OCF Per Share -$2.06

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-33K

Operating Income $-117.88M

EBITDA $-111.35M

Net Income $-111.57M

EPS (Diluted) -$4.80

Revenue / Employee N/A

Profit / Employee $-1.12M

Employees 100